nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—CYP3A5—Ifosfamide—germ cell cancer	0.0106	0.251	CbGbCtD
Crizotinib—Acute respiratory distress syndrome—Ifosfamide—germ cell cancer	0.00656	0.0331	CcSEcCtD
Crizotinib—ABCB1—Dactinomycin—germ cell cancer	0.00582	0.138	CbGbCtD
Crizotinib—Polyneuropathy—Ifosfamide—germ cell cancer	0.00526	0.0265	CcSEcCtD
Crizotinib—Periorbital oedema—Bleomycin—germ cell cancer	0.00507	0.0256	CcSEcCtD
Crizotinib—CYP3A5—Etoposide—germ cell cancer	0.00505	0.12	CbGbCtD
Crizotinib—CYP3A4—Ifosfamide—germ cell cancer	0.00412	0.0978	CbGbCtD
Crizotinib—Dysaesthesia—Ifosfamide—germ cell cancer	0.00396	0.02	CcSEcCtD
Crizotinib—CASK—Teniposide—Etoposide—germ cell cancer	0.00392	0.532	CbGdCrCtD
Crizotinib—ABCB1—Vinblastine—germ cell cancer	0.00365	0.0865	CbGbCtD
Crizotinib—ABCB1—Cisplatin—germ cell cancer	0.00334	0.0794	CbGbCtD
Crizotinib—Febrile neutropenia—Bleomycin—germ cell cancer	0.00333	0.0168	CcSEcCtD
Crizotinib—ABCB1—Etoposide—germ cell cancer	0.00328	0.078	CbGbCtD
Crizotinib—Febrile neutropenia—Dactinomycin—germ cell cancer	0.00311	0.0157	CcSEcCtD
Crizotinib—Hypophosphataemia—Ifosfamide—germ cell cancer	0.00295	0.0149	CcSEcCtD
Crizotinib—Febrile neutropenia—Ifosfamide—germ cell cancer	0.00285	0.0144	CcSEcCtD
Crizotinib—Interstitial lung disease—Bleomycin—germ cell cancer	0.00283	0.0143	CcSEcCtD
Crizotinib—Hypophosphataemia—Cisplatin—germ cell cancer	0.00254	0.0128	CcSEcCtD
Crizotinib—Generalised oedema—Cisplatin—germ cell cancer	0.00248	0.0125	CcSEcCtD
Crizotinib—Neuralgia—Ifosfamide—germ cell cancer	0.00247	0.0124	CcSEcCtD
Crizotinib—Febrile neutropenia—Cisplatin—germ cell cancer	0.00245	0.0124	CcSEcCtD
Crizotinib—Hepatotoxicity—Dactinomycin—germ cell cancer	0.00242	0.0122	CcSEcCtD
Crizotinib—Interstitial lung disease—Ifosfamide—germ cell cancer	0.00242	0.0122	CcSEcCtD
Crizotinib—Febrile neutropenia—Etoposide—germ cell cancer	0.00225	0.0113	CcSEcCtD
Crizotinib—Photophobia—Vinblastine—germ cell cancer	0.00223	0.0112	CcSEcCtD
Crizotinib—Hepatotoxicity—Ifosfamide—germ cell cancer	0.00222	0.0112	CcSEcCtD
Crizotinib—CYP3A4—Vinblastine—germ cell cancer	0.00218	0.0519	CbGbCtD
Crizotinib—ABCB1—Methotrexate—germ cell cancer	0.00217	0.0515	CbGbCtD
Crizotinib—CYP3A4—Etoposide—germ cell cancer	0.00197	0.0467	CbGbCtD
Crizotinib—PLK4—Teniposide—Etoposide—germ cell cancer	0.00194	0.263	CbGdCrCtD
Crizotinib—Hepatotoxicity—Cisplatin—germ cell cancer	0.00191	0.00965	CcSEcCtD
Crizotinib—Interstitial lung disease—Etoposide—germ cell cancer	0.00191	0.00964	CcSEcCtD
Crizotinib—Abscess—Cisplatin—germ cell cancer	0.00187	0.00942	CcSEcCtD
Crizotinib—Gait disturbance—Ifosfamide—germ cell cancer	0.00175	0.00885	CcSEcCtD
Crizotinib—Hepatotoxicity—Etoposide—germ cell cancer	0.00175	0.00884	CcSEcCtD
Crizotinib—Respiratory failure—Ifosfamide—germ cell cancer	0.00174	0.0088	CcSEcCtD
Crizotinib—Pulmonary embolism—Ifosfamide—germ cell cancer	0.00171	0.00864	CcSEcCtD
Crizotinib—Sepsis—Dactinomycin—germ cell cancer	0.00162	0.00818	CcSEcCtD
Crizotinib—AURKA—Teniposide—Etoposide—germ cell cancer	0.00152	0.206	CbGdCrCtD
Crizotinib—Hepatic failure—Dactinomycin—germ cell cancer	0.00151	0.00762	CcSEcCtD
Crizotinib—Sepsis—Ifosfamide—germ cell cancer	0.00149	0.0075	CcSEcCtD
Crizotinib—Hepatic function abnormal—Ifosfamide—germ cell cancer	0.00142	0.00718	CcSEcCtD
Crizotinib—Fluid retention—Cisplatin—germ cell cancer	0.0014	0.00707	CcSEcCtD
Crizotinib—Neuropathy—Cisplatin—germ cell cancer	0.00139	0.007	CcSEcCtD
Crizotinib—Hepatic failure—Ifosfamide—germ cell cancer	0.00138	0.00698	CcSEcCtD
Crizotinib—Phosphatase alkaline increased—Etoposide—germ cell cancer	0.00135	0.00683	CcSEcCtD
Crizotinib—Febrile neutropenia—Methotrexate—germ cell cancer	0.00135	0.0068	CcSEcCtD
Crizotinib—Neuropathy peripheral—Vinblastine—germ cell cancer	0.0013	0.00657	CcSEcCtD
Crizotinib—Neuropathy—Etoposide—germ cell cancer	0.00127	0.00641	CcSEcCtD
Crizotinib—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.00122	0.00616	CcSEcCtD
Crizotinib—Hypoaesthesia—Vinblastine—germ cell cancer	0.00119	0.00598	CcSEcCtD
Crizotinib—Sepsis—Etoposide—germ cell cancer	0.00117	0.00592	CcSEcCtD
Crizotinib—Burning sensation—Methotrexate—germ cell cancer	0.00117	0.00588	CcSEcCtD
Crizotinib—Interstitial lung disease—Methotrexate—germ cell cancer	0.00114	0.00578	CcSEcCtD
Crizotinib—Weight decreased—Bleomycin—germ cell cancer	0.00114	0.00574	CcSEcCtD
Crizotinib—Hypokalaemia—Ifosfamide—germ cell cancer	0.00113	0.00571	CcSEcCtD
Crizotinib—Blood alkaline phosphatase increased—Etoposide—germ cell cancer	0.00113	0.0057	CcSEcCtD
Crizotinib—Pneumonia—Bleomycin—germ cell cancer	0.00113	0.00569	CcSEcCtD
Crizotinib—Neutropenia—Dactinomycin—germ cell cancer	0.0011	0.00553	CcSEcCtD
Crizotinib—Pneumonia—Dactinomycin—germ cell cancer	0.00105	0.00531	CcSEcCtD
Crizotinib—Hepatotoxicity—Methotrexate—germ cell cancer	0.00105	0.00529	CcSEcCtD
Crizotinib—Face oedema—Cisplatin—germ cell cancer	0.00103	0.00522	CcSEcCtD
Crizotinib—Abscess—Methotrexate—germ cell cancer	0.00102	0.00517	CcSEcCtD
Crizotinib—Hypoaesthesia—Bleomycin—germ cell cancer	0.001	0.00505	CcSEcCtD
Crizotinib—Hypokalaemia—Cisplatin—germ cell cancer	0.000975	0.00492	CcSEcCtD
Crizotinib—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.000965	0.00487	CcSEcCtD
Crizotinib—Pneumonia—Ifosfamide—germ cell cancer	0.000964	0.00486	CcSEcCtD
Crizotinib—Anaemia—Vinblastine—germ cell cancer	0.000959	0.00484	CcSEcCtD
Crizotinib—Infestation NOS—Ifosfamide—germ cell cancer	0.000958	0.00483	CcSEcCtD
Crizotinib—Infestation—Ifosfamide—germ cell cancer	0.000958	0.00483	CcSEcCtD
Crizotinib—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.000939	0.00474	CcSEcCtD
Crizotinib—Leukopenia—Vinblastine—germ cell cancer	0.000929	0.00469	CcSEcCtD
Crizotinib—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.000906	0.00457	CcSEcCtD
Crizotinib—Bradycardia—Ifosfamide—germ cell cancer	0.000876	0.00442	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.000866	0.00437	CcSEcCtD
Crizotinib—Urinary tract disorder—Ifosfamide—germ cell cancer	0.000849	0.00429	CcSEcCtD
Crizotinib—Urethral disorder—Ifosfamide—germ cell cancer	0.000843	0.00425	CcSEcCtD
Crizotinib—Visual impairment—Ifosfamide—germ cell cancer	0.000829	0.00418	CcSEcCtD
Crizotinib—Respiratory failure—Methotrexate—germ cell cancer	0.000825	0.00416	CcSEcCtD
Crizotinib—Pulmonary embolism—Methotrexate—germ cell cancer	0.00081	0.00409	CcSEcCtD
Crizotinib—Anaemia—Bleomycin—germ cell cancer	0.00081	0.00409	CcSEcCtD
Crizotinib—Neuropathy peripheral—Cisplatin—germ cell cancer	0.00081	0.00409	CcSEcCtD
Crizotinib—Eye disorder—Ifosfamide—germ cell cancer	0.000804	0.00406	CcSEcCtD
Crizotinib—Cardiac disorder—Ifosfamide—germ cell cancer	0.000798	0.00403	CcSEcCtD
Crizotinib—Neutropenia—Etoposide—germ cell cancer	0.000794	0.004	CcSEcCtD
Crizotinib—Leukopenia—Bleomycin—germ cell cancer	0.000784	0.00396	CcSEcCtD
Crizotinib—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000781	0.00394	CcSEcCtD
Crizotinib—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000775	0.00391	CcSEcCtD
Crizotinib—Arrhythmia—Ifosfamide—germ cell cancer	0.000768	0.00388	CcSEcCtD
Crizotinib—Pneumonia—Etoposide—germ cell cancer	0.000761	0.00384	CcSEcCtD
Crizotinib—Paraesthesia—Vinblastine—germ cell cancer	0.00076	0.00384	CcSEcCtD
Crizotinib—Infestation—Etoposide—germ cell cancer	0.000757	0.00382	CcSEcCtD
Crizotinib—Infestation NOS—Etoposide—germ cell cancer	0.000757	0.00382	CcSEcCtD
Crizotinib—Anaemia—Dactinomycin—germ cell cancer	0.000755	0.00381	CcSEcCtD
Crizotinib—Bradycardia—Cisplatin—germ cell cancer	0.000755	0.00381	CcSEcCtD
Crizotinib—Malnutrition—Ifosfamide—germ cell cancer	0.000749	0.00378	CcSEcCtD
Crizotinib—Neuropathy peripheral—Etoposide—germ cell cancer	0.000742	0.00374	CcSEcCtD
Crizotinib—Decreased appetite—Vinblastine—germ cell cancer	0.000736	0.00371	CcSEcCtD
Crizotinib—Urinary tract disorder—Cisplatin—germ cell cancer	0.000732	0.00369	CcSEcCtD
Crizotinib—Leukopenia—Dactinomycin—germ cell cancer	0.000731	0.00369	CcSEcCtD
Crizotinib—Urethral disorder—Cisplatin—germ cell cancer	0.000727	0.00367	CcSEcCtD
Crizotinib—Constipation—Vinblastine—germ cell cancer	0.000724	0.00365	CcSEcCtD
Crizotinib—Hepatobiliary disease—Etoposide—germ cell cancer	0.000716	0.00361	CcSEcCtD
Crizotinib—Oedema—Bleomycin—germ cell cancer	0.000715	0.00361	CcSEcCtD
Crizotinib—Visual impairment—Cisplatin—germ cell cancer	0.000715	0.00361	CcSEcCtD
Crizotinib—Infection—Bleomycin—germ cell cancer	0.00071	0.00358	CcSEcCtD
Crizotinib—Vision blurred—Ifosfamide—germ cell cancer	0.000706	0.00356	CcSEcCtD
Crizotinib—Sepsis—Methotrexate—germ cell cancer	0.000703	0.00355	CcSEcCtD
Crizotinib—Eye disorder—Cisplatin—germ cell cancer	0.000693	0.0035	CcSEcCtD
Crizotinib—Anaemia—Ifosfamide—germ cell cancer	0.000692	0.00349	CcSEcCtD
Crizotinib—Cardiac disorder—Cisplatin—germ cell cancer	0.000688	0.00347	CcSEcCtD
Crizotinib—Hypoaesthesia—Etoposide—germ cell cancer	0.000676	0.00341	CcSEcCtD
Crizotinib—Urinary tract disorder—Etoposide—germ cell cancer	0.000671	0.00339	CcSEcCtD
Crizotinib—Leukopenia—Ifosfamide—germ cell cancer	0.00067	0.00338	CcSEcCtD
Crizotinib—Mediastinal disorder—Cisplatin—germ cell cancer	0.000668	0.00337	CcSEcCtD
Crizotinib—Oedema—Dactinomycin—germ cell cancer	0.000667	0.00336	CcSEcCtD
Crizotinib—Urethral disorder—Etoposide—germ cell cancer	0.000666	0.00336	CcSEcCtD
Crizotinib—Infection—Dactinomycin—germ cell cancer	0.000662	0.00334	CcSEcCtD
Crizotinib—Arrhythmia—Cisplatin—germ cell cancer	0.000662	0.00334	CcSEcCtD
Crizotinib—Hepatic failure—Methotrexate—germ cell cancer	0.000654	0.0033	CcSEcCtD
Crizotinib—Malnutrition—Cisplatin—germ cell cancer	0.000645	0.00326	CcSEcCtD
Crizotinib—Paraesthesia—Bleomycin—germ cell cancer	0.000642	0.00324	CcSEcCtD
Crizotinib—Dyspnoea—Bleomycin—germ cell cancer	0.000637	0.00322	CcSEcCtD
Crizotinib—Eye disorder—Etoposide—germ cell cancer	0.000635	0.0032	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000633	0.00319	CcSEcCtD
Crizotinib—Cardiac disorder—Etoposide—germ cell cancer	0.00063	0.00318	CcSEcCtD
Crizotinib—Decreased appetite—Bleomycin—germ cell cancer	0.000622	0.00314	CcSEcCtD
Crizotinib—Visual disturbance—Methotrexate—germ cell cancer	0.000621	0.00313	CcSEcCtD
Crizotinib—Mediastinal disorder—Etoposide—germ cell cancer	0.000612	0.00309	CcSEcCtD
Crizotinib—Oedema—Ifosfamide—germ cell cancer	0.000611	0.00308	CcSEcCtD
Crizotinib—Vision blurred—Cisplatin—germ cell cancer	0.000608	0.00307	CcSEcCtD
Crizotinib—Asthenia—Vinblastine—germ cell cancer	0.000607	0.00306	CcSEcCtD
Crizotinib—Infection—Ifosfamide—germ cell cancer	0.000607	0.00306	CcSEcCtD
Crizotinib—Nervous system disorder—Ifosfamide—germ cell cancer	0.000599	0.00302	CcSEcCtD
Crizotinib—Anaemia—Cisplatin—germ cell cancer	0.000597	0.00301	CcSEcCtD
Crizotinib—Skin disorder—Ifosfamide—germ cell cancer	0.000594	0.00299	CcSEcCtD
Crizotinib—Decreased appetite—Dactinomycin—germ cell cancer	0.00058	0.00292	CcSEcCtD
Crizotinib—Diarrhoea—Vinblastine—germ cell cancer	0.000579	0.00292	CcSEcCtD
Crizotinib—Dysgeusia—Etoposide—germ cell cancer	0.000579	0.00292	CcSEcCtD
Crizotinib—Leukopenia—Cisplatin—germ cell cancer	0.000578	0.00292	CcSEcCtD
Crizotinib—Fatigue—Dactinomycin—germ cell cancer	0.000575	0.0029	CcSEcCtD
Crizotinib—Body temperature increased—Bleomycin—germ cell cancer	0.000565	0.00285	CcSEcCtD
Crizotinib—Dizziness—Vinblastine—germ cell cancer	0.00056	0.00282	CcSEcCtD
Crizotinib—Paraesthesia—Ifosfamide—germ cell cancer	0.000549	0.00277	CcSEcCtD
Crizotinib—Anaemia—Etoposide—germ cell cancer	0.000547	0.00276	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000546	0.00275	CcSEcCtD
Crizotinib—Dyspnoea—Ifosfamide—germ cell cancer	0.000545	0.00275	CcSEcCtD
Crizotinib—Vomiting—Vinblastine—germ cell cancer	0.000538	0.00272	CcSEcCtD
Crizotinib—Decreased appetite—Ifosfamide—germ cell cancer	0.000531	0.00268	CcSEcCtD
Crizotinib—Leukopenia—Etoposide—germ cell cancer	0.000529	0.00267	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000528	0.00266	CcSEcCtD
Crizotinib—Body temperature increased—Dactinomycin—germ cell cancer	0.000527	0.00266	CcSEcCtD
Crizotinib—Fatigue—Ifosfamide—germ cell cancer	0.000527	0.00266	CcSEcCtD
Crizotinib—Oedema—Cisplatin—germ cell cancer	0.000527	0.00266	CcSEcCtD
Crizotinib—Infection—Cisplatin—germ cell cancer	0.000523	0.00264	CcSEcCtD
Crizotinib—Constipation—Ifosfamide—germ cell cancer	0.000523	0.00264	CcSEcCtD
Crizotinib—Loss of consciousness—Etoposide—germ cell cancer	0.00052	0.00262	CcSEcCtD
Crizotinib—Nervous system disorder—Cisplatin—germ cell cancer	0.000517	0.00261	CcSEcCtD
Crizotinib—Asthenia—Bleomycin—germ cell cancer	0.000513	0.00259	CcSEcCtD
Crizotinib—Skin disorder—Cisplatin—germ cell cancer	0.000512	0.00258	CcSEcCtD
Crizotinib—Nausea—Vinblastine—germ cell cancer	0.000503	0.00254	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.0005	0.00252	CcSEcCtD
Crizotinib—Body temperature increased—Ifosfamide—germ cell cancer	0.000483	0.00244	CcSEcCtD
Crizotinib—Infection—Etoposide—germ cell cancer	0.000479	0.00242	CcSEcCtD
Crizotinib—Asthenia—Dactinomycin—germ cell cancer	0.000478	0.00241	CcSEcCtD
Crizotinib—Neutropenia—Methotrexate—germ cell cancer	0.000475	0.0024	CcSEcCtD
Crizotinib—Paraesthesia—Cisplatin—germ cell cancer	0.000473	0.00239	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000472	0.00238	CcSEcCtD
Crizotinib—Dyspnoea—Cisplatin—germ cell cancer	0.00047	0.00237	CcSEcCtD
Crizotinib—Skin disorder—Etoposide—germ cell cancer	0.000469	0.00237	CcSEcCtD
Crizotinib—Decreased appetite—Cisplatin—germ cell cancer	0.000458	0.00231	CcSEcCtD
Crizotinib—Diarrhoea—Dactinomycin—germ cell cancer	0.000456	0.0023	CcSEcCtD
Crizotinib—Pneumonia—Methotrexate—germ cell cancer	0.000456	0.0023	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000455	0.00229	CcSEcCtD
Crizotinib—Vomiting—Bleomycin—germ cell cancer	0.000455	0.00229	CcSEcCtD
Crizotinib—Infestation NOS—Methotrexate—germ cell cancer	0.000453	0.00229	CcSEcCtD
Crizotinib—Infestation—Methotrexate—germ cell cancer	0.000453	0.00229	CcSEcCtD
Crizotinib—Rash—Bleomycin—germ cell cancer	0.000451	0.00227	CcSEcCtD
Crizotinib—Dermatitis—Bleomycin—germ cell cancer	0.00045	0.00227	CcSEcCtD
Crizotinib—Asthenia—Ifosfamide—germ cell cancer	0.000438	0.00221	CcSEcCtD
Crizotinib—Paraesthesia—Etoposide—germ cell cancer	0.000433	0.00219	CcSEcCtD
Crizotinib—Dyspnoea—Etoposide—germ cell cancer	0.00043	0.00217	CcSEcCtD
Crizotinib—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000429	0.00216	CcSEcCtD
Crizotinib—Nausea—Bleomycin—germ cell cancer	0.000425	0.00214	CcSEcCtD
Crizotinib—Vomiting—Dactinomycin—germ cell cancer	0.000424	0.00214	CcSEcCtD
Crizotinib—Rash—Dactinomycin—germ cell cancer	0.00042	0.00212	CcSEcCtD
Crizotinib—Decreased appetite—Etoposide—germ cell cancer	0.00042	0.00212	CcSEcCtD
Crizotinib—Diarrhoea—Ifosfamide—germ cell cancer	0.000418	0.00211	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000417	0.0021	CcSEcCtD
Crizotinib—Body temperature increased—Cisplatin—germ cell cancer	0.000416	0.0021	CcSEcCtD
Crizotinib—Fatigue—Etoposide—germ cell cancer	0.000416	0.0021	CcSEcCtD
Crizotinib—Constipation—Etoposide—germ cell cancer	0.000413	0.00208	CcSEcCtD
Crizotinib—Dizziness—Ifosfamide—germ cell cancer	0.000404	0.00204	CcSEcCtD
Crizotinib—Urinary tract disorder—Methotrexate—germ cell cancer	0.000402	0.00203	CcSEcCtD
Crizotinib—Urethral disorder—Methotrexate—germ cell cancer	0.000399	0.00201	CcSEcCtD
Crizotinib—Nausea—Dactinomycin—germ cell cancer	0.000396	0.002	CcSEcCtD
Crizotinib—Visual impairment—Methotrexate—germ cell cancer	0.000392	0.00198	CcSEcCtD
Crizotinib—Vomiting—Ifosfamide—germ cell cancer	0.000389	0.00196	CcSEcCtD
Crizotinib—Rash—Ifosfamide—germ cell cancer	0.000385	0.00194	CcSEcCtD
Crizotinib—Dermatitis—Ifosfamide—germ cell cancer	0.000385	0.00194	CcSEcCtD
Crizotinib—Body temperature increased—Etoposide—germ cell cancer	0.000382	0.00193	CcSEcCtD
Crizotinib—Eye disorder—Methotrexate—germ cell cancer	0.00038	0.00192	CcSEcCtD
Crizotinib—Asthenia—Cisplatin—germ cell cancer	0.000378	0.00191	CcSEcCtD
Crizotinib—Cardiac disorder—Methotrexate—germ cell cancer	0.000378	0.00191	CcSEcCtD
Crizotinib—Mediastinal disorder—Methotrexate—germ cell cancer	0.000367	0.00185	CcSEcCtD
Crizotinib—Nausea—Ifosfamide—germ cell cancer	0.000363	0.00183	CcSEcCtD
Crizotinib—Diarrhoea—Cisplatin—germ cell cancer	0.00036	0.00182	CcSEcCtD
Crizotinib—Malnutrition—Methotrexate—germ cell cancer	0.000354	0.00179	CcSEcCtD
Crizotinib—Dysgeusia—Methotrexate—germ cell cancer	0.000347	0.00175	CcSEcCtD
Crizotinib—Asthenia—Etoposide—germ cell cancer	0.000346	0.00175	CcSEcCtD
Crizotinib—Vomiting—Cisplatin—germ cell cancer	0.000335	0.00169	CcSEcCtD
Crizotinib—Vision blurred—Methotrexate—germ cell cancer	0.000334	0.00168	CcSEcCtD
Crizotinib—Rash—Cisplatin—germ cell cancer	0.000332	0.00168	CcSEcCtD
Crizotinib—Dermatitis—Cisplatin—germ cell cancer	0.000332	0.00167	CcSEcCtD
Crizotinib—Diarrhoea—Etoposide—germ cell cancer	0.00033	0.00167	CcSEcCtD
Crizotinib—Anaemia—Methotrexate—germ cell cancer	0.000327	0.00165	CcSEcCtD
Crizotinib—Dizziness—Etoposide—germ cell cancer	0.000319	0.00161	CcSEcCtD
Crizotinib—Leukopenia—Methotrexate—germ cell cancer	0.000317	0.0016	CcSEcCtD
Crizotinib—Nausea—Cisplatin—germ cell cancer	0.000313	0.00158	CcSEcCtD
Crizotinib—Vomiting—Etoposide—germ cell cancer	0.000307	0.00155	CcSEcCtD
Crizotinib—Rash—Etoposide—germ cell cancer	0.000304	0.00154	CcSEcCtD
Crizotinib—Dermatitis—Etoposide—germ cell cancer	0.000304	0.00153	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000299	0.00151	CcSEcCtD
Crizotinib—Infection—Methotrexate—germ cell cancer	0.000287	0.00145	CcSEcCtD
Crizotinib—Nausea—Etoposide—germ cell cancer	0.000287	0.00145	CcSEcCtD
Crizotinib—Nervous system disorder—Methotrexate—germ cell cancer	0.000284	0.00143	CcSEcCtD
Crizotinib—Skin disorder—Methotrexate—germ cell cancer	0.000281	0.00142	CcSEcCtD
Crizotinib—TAOK3—medulla oblongata—germ cell cancer	0.000279	0.000699	CbGeAlD
Crizotinib—PTK2—head—germ cell cancer	0.000278	0.000697	CbGeAlD
Crizotinib—TBK1—head—germ cell cancer	0.000278	0.000697	CbGeAlD
Crizotinib—SLK—female gonad—germ cell cancer	0.000278	0.000696	CbGeAlD
Crizotinib—BMPR1B—brain—germ cell cancer	0.000277	0.000694	CbGeAlD
Crizotinib—MAP4K1—brain—germ cell cancer	0.000277	0.000694	CbGeAlD
Crizotinib—MAP3K19—brain—germ cell cancer	0.000277	0.000694	CbGeAlD
Crizotinib—ABL1—brainstem—germ cell cancer	0.000276	0.000693	CbGeAlD
Crizotinib—TYK2—head—germ cell cancer	0.000276	0.000693	CbGeAlD
Crizotinib—EPHB4—female gonad—germ cell cancer	0.000276	0.000691	CbGeAlD
Crizotinib—MAP3K2—testis—germ cell cancer	0.000274	0.000688	CbGeAlD
Crizotinib—JAK2—female gonad—germ cell cancer	0.000274	0.000686	CbGeAlD
Crizotinib—MAP3K3—bone marrow—germ cell cancer	0.000274	0.000686	CbGeAlD
Crizotinib—MAP4K5—bone marrow—germ cell cancer	0.000274	0.000686	CbGeAlD
Crizotinib—ALK—lymph node—germ cell cancer	0.000273	0.000685	CbGeAlD
Crizotinib—FER—lymph node—germ cell cancer	0.000273	0.000685	CbGeAlD
Crizotinib—TEK—spinal cord—germ cell cancer	0.000273	0.000683	CbGeAlD
Crizotinib—MAP4K5—spinal cord—germ cell cancer	0.000273	0.000683	CbGeAlD
Crizotinib—MAP3K3—spinal cord—germ cell cancer	0.000273	0.000683	CbGeAlD
Crizotinib—TNK2—brain—germ cell cancer	0.000272	0.000681	CbGeAlD
Crizotinib—IGF1R—brain—germ cell cancer	0.000272	0.000681	CbGeAlD
Crizotinib—RPS6KB1—endocrine gland—germ cell cancer	0.000271	0.000679	CbGeAlD
Crizotinib—EPHA2—female gonad—germ cell cancer	0.000271	0.000678	CbGeAlD
Crizotinib—EPHB6—adrenal gland—germ cell cancer	0.00027	0.000678	CbGeAlD
Crizotinib—TNK1—lymph node—germ cell cancer	0.00027	0.000678	CbGeAlD
Crizotinib—PTK2B—cerebellum—germ cell cancer	0.00027	0.000676	CbGeAlD
Crizotinib—FGR—endocrine gland—germ cell cancer	0.000269	0.000675	CbGeAlD
Crizotinib—ABL1—eye—germ cell cancer	0.000269	0.000675	CbGeAlD
Crizotinib—TBK1—testis—germ cell cancer	0.000269	0.000674	CbGeAlD
Crizotinib—PTK2—testis—germ cell cancer	0.000269	0.000674	CbGeAlD
Crizotinib—AXL—endocrine gland—germ cell cancer	0.000268	0.000673	CbGeAlD
Crizotinib—MAP4K2—brain—germ cell cancer	0.000268	0.000671	CbGeAlD
Crizotinib—BMPR1B—lymph node—germ cell cancer	0.000268	0.000671	CbGeAlD
Crizotinib—MAP4K1—lymph node—germ cell cancer	0.000268	0.000671	CbGeAlD
Crizotinib—RPS6KB1—head—germ cell cancer	0.000268	0.000671	CbGeAlD
Crizotinib—RIPK2—cerebellum—germ cell cancer	0.000267	0.00067	CbGeAlD
Crizotinib—EPHB6—midbrain—germ cell cancer	0.000267	0.000669	CbGeAlD
Crizotinib—TYK2—testis—germ cell cancer	0.000267	0.000669	CbGeAlD
Crizotinib—ABL1—retina—germ cell cancer	0.000267	0.000669	CbGeAlD
Crizotinib—FGR—head—germ cell cancer	0.000266	0.000667	CbGeAlD
Crizotinib—AXL—head—germ cell cancer	0.000265	0.000664	CbGeAlD
Crizotinib—STK3—brain—germ cell cancer	0.000264	0.000662	CbGeAlD
Crizotinib—TIE1—brain—germ cell cancer	0.000264	0.000662	CbGeAlD
Crizotinib—TEK—female gonad—germ cell cancer	0.000264	0.000661	CbGeAlD
Crizotinib—MAP4K5—female gonad—germ cell cancer	0.000264	0.000661	CbGeAlD
Crizotinib—MAP3K3—female gonad—germ cell cancer	0.000264	0.000661	CbGeAlD
Crizotinib—IRAK1—testis—germ cell cancer	0.000263	0.00066	CbGeAlD
Crizotinib—TNK2—lymph node—germ cell cancer	0.000262	0.000658	CbGeAlD
Crizotinib—IGF1R—lymph node—germ cell cancer	0.000262	0.000658	CbGeAlD
Crizotinib—YES1—adrenal gland—germ cell cancer	0.000261	0.000655	CbGeAlD
Crizotinib—EPHB6—spinal cord—germ cell cancer	0.000261	0.000653	CbGeAlD
Crizotinib—Paraesthesia—Methotrexate—germ cell cancer	0.00026	0.00131	CcSEcCtD
Crizotinib—STK10—adrenal gland—germ cell cancer	0.000259	0.000649	CbGeAlD
Crizotinib—CSF1R—gonad—germ cell cancer	0.000259	0.000649	CbGeAlD
Crizotinib—MAP4K2—lymph node—germ cell cancer	0.000259	0.000649	CbGeAlD
Crizotinib—RPS6KB1—testis—germ cell cancer	0.000259	0.000648	CbGeAlD
Crizotinib—EPHA4—cerebellum—germ cell cancer	0.000258	0.000648	CbGeAlD
Crizotinib—YES1—midbrain—germ cell cancer	0.000258	0.000647	CbGeAlD
Crizotinib—TAOK3—adrenal gland—germ cell cancer	0.000258	0.000647	CbGeAlD
Crizotinib—Dyspnoea—Methotrexate—germ cell cancer	0.000258	0.0013	CcSEcCtD
Crizotinib—AURKA—brain—germ cell cancer	0.000257	0.000645	CbGeAlD
Crizotinib—CSF1R—uterus—germ cell cancer	0.000257	0.000645	CbGeAlD
Crizotinib—FGR—testis—germ cell cancer	0.000257	0.000644	CbGeAlD
Crizotinib—LCK—testis—germ cell cancer	0.000257	0.000644	CbGeAlD
Crizotinib—EPHB4—endocrine gland—germ cell cancer	0.000256	0.000643	CbGeAlD
Crizotinib—AXL—testis—germ cell cancer	0.000256	0.000641	CbGeAlD
Crizotinib—TESK1—brain—germ cell cancer	0.000255	0.00064	CbGeAlD
Crizotinib—STK3—lymph node—germ cell cancer	0.000255	0.00064	CbGeAlD
Crizotinib—TIE1—lymph node—germ cell cancer	0.000255	0.00064	CbGeAlD
Crizotinib—TAOK3—midbrain—germ cell cancer	0.000255	0.000639	CbGeAlD
Crizotinib—JAK2—endocrine gland—germ cell cancer	0.000255	0.000638	CbGeAlD
Crizotinib—Dyspepsia—Methotrexate—germ cell cancer	0.000254	0.00128	CcSEcCtD
Crizotinib—MAP3K2—cerebellum—germ cell cancer	0.000253	0.000635	CbGeAlD
Crizotinib—YES1—bone marrow—germ cell cancer	0.000253	0.000634	CbGeAlD
Crizotinib—CSF1R—pituitary gland—germ cell cancer	0.000253	0.000633	CbGeAlD
Crizotinib—EPHB6—female gonad—germ cell cancer	0.000252	0.000632	CbGeAlD
Crizotinib—YES1—spinal cord—germ cell cancer	0.000252	0.000631	CbGeAlD
Crizotinib—EPHA2—endocrine gland—germ cell cancer	0.000252	0.000631	CbGeAlD
Crizotinib—SRC—adrenal gland—germ cell cancer	0.000251	0.00063	CbGeAlD
Crizotinib—JAK2—head—germ cell cancer	0.000251	0.00063	CbGeAlD
Crizotinib—Decreased appetite—Methotrexate—germ cell cancer	0.000251	0.00127	CcSEcCtD
Crizotinib—STK10—bone marrow—germ cell cancer	0.000251	0.000628	CbGeAlD
Crizotinib—TAOK3—bone marrow—germ cell cancer	0.00025	0.000626	CbGeAlD
Crizotinib—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00025	0.00126	CcSEcCtD
Crizotinib—Fatigue—Methotrexate—germ cell cancer	0.000249	0.00126	CcSEcCtD
Crizotinib—AURKA—lymph node—germ cell cancer	0.000249	0.000624	CbGeAlD
Crizotinib—TAOK3—spinal cord—germ cell cancer	0.000249	0.000623	CbGeAlD
Crizotinib—MERTK—brain—germ cell cancer	0.000248	0.000623	CbGeAlD
Crizotinib—EPHA2—head—germ cell cancer	0.000248	0.000623	CbGeAlD
Crizotinib—PTK2—cerebellum—germ cell cancer	0.000248	0.000622	CbGeAlD
Crizotinib—TBK1—cerebellum—germ cell cancer	0.000248	0.000622	CbGeAlD
Crizotinib—TESK1—lymph node—germ cell cancer	0.000247	0.000619	CbGeAlD
Crizotinib—TYK2—cerebellum—germ cell cancer	0.000247	0.000618	CbGeAlD
Crizotinib—SLK—testis—germ cell cancer	0.000246	0.000617	CbGeAlD
Crizotinib—MAP4K5—endocrine gland—germ cell cancer	0.000245	0.000615	CbGeAlD
Crizotinib—MAP3K3—endocrine gland—germ cell cancer	0.000245	0.000615	CbGeAlD
Crizotinib—TEK—endocrine gland—germ cell cancer	0.000245	0.000615	CbGeAlD
Crizotinib—ABL1—telencephalon—germ cell cancer	0.000245	0.000615	CbGeAlD
Crizotinib—EPHB4—testis—germ cell cancer	0.000245	0.000613	CbGeAlD
Crizotinib—CSF1R—medulla oblongata—germ cell cancer	0.000244	0.000611	CbGeAlD
Crizotinib—YES1—female gonad—germ cell cancer	0.000244	0.000611	CbGeAlD
Crizotinib—IRAK1—cerebellum—germ cell cancer	0.000243	0.00061	CbGeAlD
Crizotinib—LIMK2—brain—germ cell cancer	0.000243	0.000609	CbGeAlD
Crizotinib—JAK2—testis—germ cell cancer	0.000243	0.000609	CbGeAlD
Crizotinib—MAP3K3—head—germ cell cancer	0.000242	0.000607	CbGeAlD
Crizotinib—TEK—head—germ cell cancer	0.000242	0.000607	CbGeAlD
Crizotinib—MAP4K5—head—germ cell cancer	0.000242	0.000607	CbGeAlD
Crizotinib—SRC—spinal cord—germ cell cancer	0.000242	0.000607	CbGeAlD
Crizotinib—NUAK2—brain—germ cell cancer	0.000242	0.000607	CbGeAlD
Crizotinib—STK10—female gonad—germ cell cancer	0.000242	0.000605	CbGeAlD
Crizotinib—TAOK3—female gonad—germ cell cancer	0.000241	0.000603	CbGeAlD
Crizotinib—MAP3K12—brain—germ cell cancer	0.00024	0.000603	CbGeAlD
Crizotinib—ACVR1—brain—germ cell cancer	0.00024	0.000603	CbGeAlD
Crizotinib—MERTK—lymph node—germ cell cancer	0.00024	0.000602	CbGeAlD
Crizotinib—EPHA2—testis—germ cell cancer	0.00024	0.000601	CbGeAlD
Crizotinib—RPS6KB1—cerebellum—germ cell cancer	0.000239	0.000598	CbGeAlD
Crizotinib—AXL—cerebellum—germ cell cancer	0.000236	0.000592	CbGeAlD
Crizotinib—STK35—brain—germ cell cancer	0.000236	0.00059	CbGeAlD
Crizotinib—LIMK2—lymph node—germ cell cancer	0.000235	0.000588	CbGeAlD
Crizotinib—SRC—female gonad—germ cell cancer	0.000234	0.000588	CbGeAlD
Crizotinib—ABL1—skin of body—germ cell cancer	0.000234	0.000587	CbGeAlD
Crizotinib—MAP3K3—testis—germ cell cancer	0.000234	0.000587	CbGeAlD
Crizotinib—MAP4K5—testis—germ cell cancer	0.000234	0.000587	CbGeAlD
Crizotinib—TEK—testis—germ cell cancer	0.000234	0.000587	CbGeAlD
Crizotinib—NUAK2—lymph node—germ cell cancer	0.000234	0.000586	CbGeAlD
Crizotinib—ABL1—decidua—germ cell cancer	0.000233	0.000583	CbGeAlD
Crizotinib—MAP3K12—lymph node—germ cell cancer	0.000232	0.000582	CbGeAlD
Crizotinib—ACVR1—lymph node—germ cell cancer	0.000232	0.000582	CbGeAlD
Crizotinib—FLT3—lymph node—germ cell cancer	0.000232	0.000582	CbGeAlD
Crizotinib—EPHB6—head—germ cell cancer	0.000232	0.00058	CbGeAlD
Crizotinib—ABL2—brain—germ cell cancer	0.000229	0.000575	CbGeAlD
Crizotinib—Body temperature increased—Methotrexate—germ cell cancer	0.000229	0.00115	CcSEcCtD
Crizotinib—STK35—lymph node—germ cell cancer	0.000228	0.00057	CbGeAlD
Crizotinib—SLK—cerebellum—germ cell cancer	0.000228	0.00057	CbGeAlD
Crizotinib—BMP2K—brain—germ cell cancer	0.000227	0.000568	CbGeAlD
Crizotinib—YES1—endocrine gland—germ cell cancer	0.000227	0.000568	CbGeAlD
Crizotinib—EPHB4—cerebellum—germ cell cancer	0.000226	0.000566	CbGeAlD
Crizotinib—CSF1R—adrenal gland—germ cell cancer	0.000226	0.000566	CbGeAlD
Crizotinib—STK10—endocrine gland—germ cell cancer	0.000225	0.000563	CbGeAlD
Crizotinib—JAK2—cerebellum—germ cell cancer	0.000224	0.000562	CbGeAlD
Crizotinib—YES1—head—germ cell cancer	0.000224	0.000561	CbGeAlD
Crizotinib—TAOK3—endocrine gland—germ cell cancer	0.000224	0.000561	CbGeAlD
Crizotinib—EPHB6—testis—germ cell cancer	0.000224	0.000561	CbGeAlD
Crizotinib—CSF1R—midbrain—germ cell cancer	0.000223	0.000559	CbGeAlD
Crizotinib—ABL2—lymph node—germ cell cancer	0.000222	0.000556	CbGeAlD
Crizotinib—STK10—head—germ cell cancer	0.000222	0.000556	CbGeAlD
Crizotinib—TAOK3—head—germ cell cancer	0.000221	0.000554	CbGeAlD
Crizotinib—BMP2K—lymph node—germ cell cancer	0.000219	0.000549	CbGeAlD
Crizotinib—PTK2B—brain—germ cell cancer	0.000219	0.000549	CbGeAlD
Crizotinib—CSF1R—bone marrow—germ cell cancer	0.000218	0.000547	CbGeAlD
Crizotinib—SRC—endocrine gland—germ cell cancer	0.000218	0.000547	CbGeAlD
Crizotinib—CSF1R—spinal cord—germ cell cancer	0.000217	0.000545	CbGeAlD
Crizotinib—RIPK2—brain—germ cell cancer	0.000217	0.000544	CbGeAlD
Crizotinib—MAP3K3—cerebellum—germ cell cancer	0.000216	0.000542	CbGeAlD
Crizotinib—MAP4K5—cerebellum—germ cell cancer	0.000216	0.000542	CbGeAlD
Crizotinib—TEK—cerebellum—germ cell cancer	0.000216	0.000542	CbGeAlD
Crizotinib—YES1—testis—germ cell cancer	0.000216	0.000542	CbGeAlD
Crizotinib—SRC—head—germ cell cancer	0.000215	0.00054	CbGeAlD
Crizotinib—STK10—testis—germ cell cancer	0.000214	0.000537	CbGeAlD
Crizotinib—TAOK3—testis—germ cell cancer	0.000213	0.000535	CbGeAlD
Crizotinib—PTK2B—lymph node—germ cell cancer	0.000212	0.00053	CbGeAlD
Crizotinib—CSF1R—female gonad—germ cell cancer	0.00021	0.000528	CbGeAlD
Crizotinib—EPHA4—brain—germ cell cancer	0.00021	0.000526	CbGeAlD
Crizotinib—RIPK2—lymph node—germ cell cancer	0.00021	0.000526	CbGeAlD
Crizotinib—SRC—testis—germ cell cancer	0.000208	0.000521	CbGeAlD
Crizotinib—Asthenia—Methotrexate—germ cell cancer	0.000207	0.00105	CcSEcCtD
Crizotinib—EPHB6—cerebellum—germ cell cancer	0.000207	0.000518	CbGeAlD
Crizotinib—MAP3K2—brain—germ cell cancer	0.000206	0.000516	CbGeAlD
Crizotinib—ABL1—gonad—germ cell cancer	0.000205	0.000513	CbGeAlD
Crizotinib—ABL1—uterus—germ cell cancer	0.000203	0.00051	CbGeAlD
Crizotinib—EPHA4—lymph node—germ cell cancer	0.000203	0.000508	CbGeAlD
Crizotinib—TBK1—brain—germ cell cancer	0.000202	0.000505	CbGeAlD
Crizotinib—PTK2—brain—germ cell cancer	0.000202	0.000505	CbGeAlD
Crizotinib—TYK2—brain—germ cell cancer	0.0002	0.000502	CbGeAlD
Crizotinib—ABL1—pituitary gland—germ cell cancer	0.0002	0.000501	CbGeAlD
Crizotinib—YES1—cerebellum—germ cell cancer	0.0002	0.0005	CbGeAlD
Crizotinib—MAP3K2—lymph node—germ cell cancer	0.000199	0.000499	CbGeAlD
Crizotinib—STK10—cerebellum—germ cell cancer	0.000198	0.000496	CbGeAlD
Crizotinib—Diarrhoea—Methotrexate—germ cell cancer	0.000198	0.000998	CcSEcCtD
Crizotinib—IRAK1—brain—germ cell cancer	0.000198	0.000495	CbGeAlD
Crizotinib—TAOK3—cerebellum—germ cell cancer	0.000197	0.000494	CbGeAlD
Crizotinib—CSF1R—endocrine gland—germ cell cancer	0.000196	0.000491	CbGeAlD
Crizotinib—PTK2—lymph node—germ cell cancer	0.000195	0.000488	CbGeAlD
Crizotinib—TBK1—lymph node—germ cell cancer	0.000195	0.000488	CbGeAlD
Crizotinib—RPS6KB1—brain—germ cell cancer	0.000194	0.000486	CbGeAlD
Crizotinib—TYK2—lymph node—germ cell cancer	0.000193	0.000485	CbGeAlD
Crizotinib—CSF1R—head—germ cell cancer	0.000193	0.000484	CbGeAlD
Crizotinib—ABL1—medulla oblongata—germ cell cancer	0.000193	0.000483	CbGeAlD
Crizotinib—FGR—brain—germ cell cancer	0.000193	0.000483	CbGeAlD
Crizotinib—SRC—cerebellum—germ cell cancer	0.000192	0.000481	CbGeAlD
Crizotinib—AXL—brain—germ cell cancer	0.000192	0.000481	CbGeAlD
Crizotinib—Dizziness—Methotrexate—germ cell cancer	0.000191	0.000965	CcSEcCtD
Crizotinib—IRAK1—lymph node—germ cell cancer	0.000191	0.000479	CbGeAlD
Crizotinib—RPS6KB1—lymph node—germ cell cancer	0.000187	0.00047	CbGeAlD
Crizotinib—CSF1R—testis—germ cell cancer	0.000187	0.000468	CbGeAlD
Crizotinib—LCK—lymph node—germ cell cancer	0.000186	0.000467	CbGeAlD
Crizotinib—FGR—lymph node—germ cell cancer	0.000186	0.000467	CbGeAlD
Crizotinib—AXL—lymph node—germ cell cancer	0.000186	0.000465	CbGeAlD
Crizotinib—SLK—brain—germ cell cancer	0.000185	0.000463	CbGeAlD
Crizotinib—Vomiting—Methotrexate—germ cell cancer	0.000184	0.000927	CcSEcCtD
Crizotinib—EPHB4—brain—germ cell cancer	0.000183	0.00046	CbGeAlD
Crizotinib—Rash—Methotrexate—germ cell cancer	0.000182	0.00092	CcSEcCtD
Crizotinib—JAK2—brain—germ cell cancer	0.000182	0.000457	CbGeAlD
Crizotinib—Dermatitis—Methotrexate—germ cell cancer	0.000182	0.000919	CcSEcCtD
Crizotinib—EPHA2—brain—germ cell cancer	0.00018	0.000451	CbGeAlD
Crizotinib—SLK—lymph node—germ cell cancer	0.000179	0.000448	CbGeAlD
Crizotinib—ABL1—adrenal gland—germ cell cancer	0.000178	0.000447	CbGeAlD
Crizotinib—EPHB4—lymph node—germ cell cancer	0.000177	0.000444	CbGeAlD
Crizotinib—ABL1—midbrain—germ cell cancer	0.000176	0.000442	CbGeAlD
Crizotinib—JAK2—lymph node—germ cell cancer	0.000176	0.000441	CbGeAlD
Crizotinib—MAP3K3—brain—germ cell cancer	0.000176	0.00044	CbGeAlD
Crizotinib—TEK—brain—germ cell cancer	0.000176	0.00044	CbGeAlD
Crizotinib—MAP4K5—brain—germ cell cancer	0.000176	0.00044	CbGeAlD
Crizotinib—EPHA2—lymph node—germ cell cancer	0.000174	0.000436	CbGeAlD
Crizotinib—ABL1—bone marrow—germ cell cancer	0.000173	0.000433	CbGeAlD
Crizotinib—CSF1R—cerebellum—germ cell cancer	0.000172	0.000432	CbGeAlD
Crizotinib—ABL1—spinal cord—germ cell cancer	0.000172	0.000431	CbGeAlD
Crizotinib—Nausea—Methotrexate—germ cell cancer	0.000172	0.000866	CcSEcCtD
Crizotinib—MAP4K5—lymph node—germ cell cancer	0.00017	0.000425	CbGeAlD
Crizotinib—MAP3K3—lymph node—germ cell cancer	0.00017	0.000425	CbGeAlD
Crizotinib—TEK—lymph node—germ cell cancer	0.00017	0.000425	CbGeAlD
Crizotinib—EPHB6—brain—germ cell cancer	0.000168	0.000421	CbGeAlD
Crizotinib—ABL1—female gonad—germ cell cancer	0.000166	0.000417	CbGeAlD
Crizotinib—YES1—brain—germ cell cancer	0.000162	0.000406	CbGeAlD
Crizotinib—EPHB6—lymph node—germ cell cancer	0.000162	0.000406	CbGeAlD
Crizotinib—STK10—brain—germ cell cancer	0.000161	0.000403	CbGeAlD
Crizotinib—TAOK3—brain—germ cell cancer	0.00016	0.000401	CbGeAlD
Crizotinib—ABCB1—blood vessel—germ cell cancer	0.000157	0.000394	CbGeAlD
Crizotinib—YES1—lymph node—germ cell cancer	0.000157	0.000393	CbGeAlD
Crizotinib—SRC—brain—germ cell cancer	0.000156	0.000391	CbGeAlD
Crizotinib—STK10—lymph node—germ cell cancer	0.000155	0.000389	CbGeAlD
Crizotinib—ABL1—endocrine gland—germ cell cancer	0.000155	0.000388	CbGeAlD
Crizotinib—TAOK3—lymph node—germ cell cancer	0.000155	0.000388	CbGeAlD
Crizotinib—ABL1—head—germ cell cancer	0.000153	0.000383	CbGeAlD
Crizotinib—SRC—lymph node—germ cell cancer	0.000151	0.000378	CbGeAlD
Crizotinib—ABL1—testis—germ cell cancer	0.000148	0.00037	CbGeAlD
Crizotinib—CSF1R—brain—germ cell cancer	0.00014	0.000351	CbGeAlD
Crizotinib—ABL1—cerebellum—germ cell cancer	0.000136	0.000342	CbGeAlD
Crizotinib—CSF1R—lymph node—germ cell cancer	0.000135	0.000339	CbGeAlD
Crizotinib—ABL1—brain—germ cell cancer	0.000111	0.000277	CbGeAlD
Crizotinib—ABL1—lymph node—germ cell cancer	0.000107	0.000268	CbGeAlD
Crizotinib—CYP3A5—female gonad—germ cell cancer	9.74e-05	0.000244	CbGeAlD
Crizotinib—ABCB1—trigeminal ganglion—germ cell cancer	9.71e-05	0.000243	CbGeAlD
Crizotinib—ABCB1—embryo—germ cell cancer	9.38e-05	0.000235	CbGeAlD
Crizotinib—CYP3A5—endocrine gland—germ cell cancer	9.06e-05	0.000227	CbGeAlD
Crizotinib—ABCB1—retina—germ cell cancer	8.29e-05	0.000208	CbGeAlD
Crizotinib—ABCB1—telencephalon—germ cell cancer	7.63e-05	0.000191	CbGeAlD
Crizotinib—ABCB1—decidua—germ cell cancer	7.23e-05	0.000181	CbGeAlD
Crizotinib—CYP3A4—endocrine gland—germ cell cancer	6.8e-05	0.00017	CbGeAlD
Crizotinib—ABCB1—gonad—germ cell cancer	6.37e-05	0.00016	CbGeAlD
Crizotinib—ABCB1—uterus—germ cell cancer	6.33e-05	0.000159	CbGeAlD
Crizotinib—ABCB1—pituitary gland—germ cell cancer	6.21e-05	0.000156	CbGeAlD
Crizotinib—ABCB1—medulla oblongata—germ cell cancer	5.99e-05	0.00015	CbGeAlD
Crizotinib—ABCB1—adrenal gland—germ cell cancer	5.55e-05	0.000139	CbGeAlD
Crizotinib—ABCB1—midbrain—germ cell cancer	5.48e-05	0.000137	CbGeAlD
Crizotinib—ABCB1—bone marrow—germ cell cancer	5.37e-05	0.000135	CbGeAlD
Crizotinib—ABCB1—spinal cord—germ cell cancer	5.35e-05	0.000134	CbGeAlD
Crizotinib—ABCB1—female gonad—germ cell cancer	5.17e-05	0.00013	CbGeAlD
Crizotinib—ABCB1—endocrine gland—germ cell cancer	4.81e-05	0.000121	CbGeAlD
Crizotinib—ABCB1—head—germ cell cancer	4.75e-05	0.000119	CbGeAlD
Crizotinib—ABCB1—testis—germ cell cancer	4.59e-05	0.000115	CbGeAlD
Crizotinib—ABCB1—cerebellum—germ cell cancer	4.24e-05	0.000106	CbGeAlD
Crizotinib—ABCB1—brain—germ cell cancer	3.44e-05	8.63e-05	CbGeAlD
Crizotinib—ABCB1—lymph node—germ cell cancer	3.33e-05	8.34e-05	CbGeAlD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.24e-05	6.35e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling by EGFR in Cancer—HRAS—germ cell cancer	2.24e-05	6.34e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—KIT—germ cell cancer	2.24e-05	6.33e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—FGFR3—germ cell cancer	2.23e-05	6.32e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling by PDGF—HRAS—germ cell cancer	2.23e-05	6.31e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—KIT—germ cell cancer	2.22e-05	6.29e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—OXT—germ cell cancer	2.22e-05	6.29e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—FGF4—germ cell cancer	2.22e-05	6.29e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—SLC22A3—germ cell cancer	2.21e-05	6.27e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—FGFR3—germ cell cancer	2.21e-05	6.26e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—KIT—germ cell cancer	2.21e-05	6.24e-05	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—MYC—germ cell cancer	2.18e-05	6.16e-05	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—HRAS—germ cell cancer	2.18e-05	6.16e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—H2AFZ—germ cell cancer	2.16e-05	6.1e-05	CbGpPWpGaD
Crizotinib—SRC—Focal Adhesion—HRAS—germ cell cancer	2.15e-05	6.1e-05	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—HRAS—germ cell cancer	2.15e-05	6.09e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—FGFR3—germ cell cancer	2.14e-05	6.07e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—FGF4—germ cell cancer	2.13e-05	6.03e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—KITLG—germ cell cancer	2.12e-05	6e-05	CbGpPWpGaD
Crizotinib—RIPK2—Innate Immune System—HRAS—germ cell cancer	2.12e-05	5.99e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—KIT—germ cell cancer	2.09e-05	5.92e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—H2AFZ—germ cell cancer	2.09e-05	5.92e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—KITLG—germ cell cancer	2.09e-05	5.92e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—KITLG—germ cell cancer	2.08e-05	5.9e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—OXT—germ cell cancer	2.08e-05	5.89e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—AVP—germ cell cancer	2.07e-05	5.86e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—KIT—germ cell cancer	2.07e-05	5.85e-05	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—HRAS—germ cell cancer	2.06e-05	5.82e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—KIT—germ cell cancer	2.05e-05	5.8e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—HRAS—germ cell cancer	2.05e-05	5.8e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—AVP—germ cell cancer	2.04e-05	5.78e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—FGFR3—germ cell cancer	2.04e-05	5.78e-05	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—HRAS—germ cell cancer	2.04e-05	5.77e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—KIT—germ cell cancer	2.03e-05	5.75e-05	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—HRAS—germ cell cancer	2.03e-05	5.75e-05	CbGpPWpGaD
Crizotinib—FGR—Innate Immune System—HRAS—germ cell cancer	2.03e-05	5.74e-05	CbGpPWpGaD
Crizotinib—SRC—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	2.02e-05	5.71e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—FGFR3—germ cell cancer	2.01e-05	5.68e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by NGF—HRAS—germ cell cancer	2e-05	5.67e-05	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—MYC—germ cell cancer	1.99e-05	5.64e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—H2AFZ—germ cell cancer	1.98e-05	5.61e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—KITLG—germ cell cancer	1.98e-05	5.61e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—FGFR3—germ cell cancer	1.98e-05	5.6e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—KITLG—germ cell cancer	1.98e-05	5.59e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—KIT—germ cell cancer	1.97e-05	5.57e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—FGF4—germ cell cancer	1.97e-05	5.56e-05	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—HRAS—germ cell cancer	1.95e-05	5.53e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—AVP—germ cell cancer	1.94e-05	5.48e-05	CbGpPWpGaD
Crizotinib—LYN—Axon guidance—HRAS—germ cell cancer	1.94e-05	5.48e-05	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—TP53—germ cell cancer	1.93e-05	5.46e-05	CbGpPWpGaD
Crizotinib—ABL1—Axon guidance—HRAS—germ cell cancer	1.93e-05	5.46e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—KITLG—germ cell cancer	1.93e-05	5.45e-05	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—TP53—germ cell cancer	1.9e-05	5.38e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—FGF4—germ cell cancer	1.9e-05	5.37e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—FGFR3—germ cell cancer	1.89e-05	5.36e-05	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—TP53—germ cell cancer	1.89e-05	5.34e-05	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—TP53—germ cell cancer	1.89e-05	5.34e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—AVP—germ cell cancer	1.88e-05	5.32e-05	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—HRAS—germ cell cancer	1.88e-05	5.32e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—KIT—germ cell cancer	1.88e-05	5.31e-05	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—HRAS—germ cell cancer	1.87e-05	5.3e-05	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—HRAS—germ cell cancer	1.87e-05	5.3e-05	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—HRAS—germ cell cancer	1.85e-05	5.25e-05	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—HRAS—germ cell cancer	1.84e-05	5.22e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—KIT—germ cell cancer	1.84e-05	5.22e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—FGFR3—germ cell cancer	1.84e-05	5.2e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—KITLG—germ cell cancer	1.82e-05	5.16e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—OXT—germ cell cancer	1.82e-05	5.16e-05	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—HRAS—germ cell cancer	1.82e-05	5.15e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—KIT—germ cell cancer	1.82e-05	5.14e-05	CbGpPWpGaD
Crizotinib—JAK2—Axon guidance—HRAS—germ cell cancer	1.81e-05	5.13e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CRABP1—germ cell cancer	1.8e-05	5.11e-05	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—HRAS—germ cell cancer	1.8e-05	5.1e-05	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—HRAS—germ cell cancer	1.8e-05	5.1e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—FGFR3—germ cell cancer	1.79e-05	5.07e-05	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—TP53—germ cell cancer	1.79e-05	5.06e-05	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—HRAS—germ cell cancer	1.78e-05	5.05e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—FGFR3—germ cell cancer	1.78e-05	5.05e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—FGF4—germ cell cancer	1.78e-05	5.03e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—H2AFZ—germ cell cancer	1.76e-05	4.97e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling by NGF—HRAS—germ cell cancer	1.75e-05	4.96e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—KITLG—germ cell cancer	1.75e-05	4.95e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—MYC—germ cell cancer	1.74e-05	4.93e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—KIT—germ cell cancer	1.74e-05	4.92e-05	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—HRAS—germ cell cancer	1.71e-05	4.84e-05	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—HRAS—germ cell cancer	1.71e-05	4.83e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.7e-05	4.8e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—H2AFZ—germ cell cancer	1.69e-05	4.8e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—KIT—germ cell cancer	1.69e-05	4.77e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—FGFR3—germ cell cancer	1.68e-05	4.75e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.67e-05	4.73e-05	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.67e-05	4.73e-05	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—HRAS—germ cell cancer	1.66e-05	4.7e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—KIT—germ cell cancer	1.65e-05	4.66e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—KIT—germ cell cancer	1.64e-05	4.63e-05	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—HRAS—germ cell cancer	1.64e-05	4.63e-05	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—TP53—germ cell cancer	1.64e-05	4.63e-05	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—MYC—germ cell cancer	1.64e-05	4.63e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.62e-05	4.57e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—KITLG—germ cell cancer	1.62e-05	4.57e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—OXT—germ cell cancer	1.61e-05	4.57e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—H2AFZ—germ cell cancer	1.59e-05	4.49e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—FGFR3—germ cell cancer	1.58e-05	4.46e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—MYC—germ cell cancer	1.57e-05	4.45e-05	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—HRAS—germ cell cancer	1.57e-05	4.45e-05	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—HRAS—germ cell cancer	1.56e-05	4.43e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—KITLG—germ cell cancer	1.56e-05	4.41e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—FGF4—germ cell cancer	1.56e-05	4.4e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—FGFR3—germ cell cancer	1.55e-05	4.4e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—HRAS—germ cell cancer	1.55e-05	4.4e-05	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—HRAS—germ cell cancer	1.55e-05	4.39e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—FGFR3—germ cell cancer	1.55e-05	4.38e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—MYC—germ cell cancer	1.54e-05	4.36e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—KIT—germ cell cancer	1.54e-05	4.36e-05	CbGpPWpGaD
Crizotinib—TBK1—Immune System—HRAS—germ cell cancer	1.53e-05	4.33e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—AVP—germ cell cancer	1.52e-05	4.31e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—MYC—germ cell cancer	1.52e-05	4.3e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—HRAS—germ cell cancer	1.51e-05	4.28e-05	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—HRAS—germ cell cancer	1.51e-05	4.27e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—FGFR3—germ cell cancer	1.47e-05	4.17e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—FGFR3—germ cell cancer	1.47e-05	4.16e-05	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—HRAS—germ cell cancer	1.47e-05	4.15e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—KITLG—germ cell cancer	1.46e-05	4.13e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—KIT—germ cell cancer	1.45e-05	4.09e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—FGFR3—germ cell cancer	1.43e-05	4.05e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—TP53—germ cell cancer	1.43e-05	4.05e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—KIT—germ cell cancer	1.43e-05	4.04e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—AVP—germ cell cancer	1.43e-05	4.04e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—KIT—germ cell cancer	1.42e-05	4.02e-05	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—TP53—germ cell cancer	1.42e-05	4.01e-05	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—TP53—germ cell cancer	1.41e-05	3.99e-05	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—HRAS—germ cell cancer	1.41e-05	3.98e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—H2AFZ—germ cell cancer	1.39e-05	3.93e-05	CbGpPWpGaD
Crizotinib—JAK3—Immune System—HRAS—germ cell cancer	1.38e-05	3.91e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—HRAS—germ cell cancer	1.38e-05	3.91e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—FGF4—germ cell cancer	1.38e-05	3.9e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—HRAS—germ cell cancer	1.38e-05	3.89e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—HRAS—germ cell cancer	1.37e-05	3.87e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CRABP1—germ cell cancer	1.36e-05	3.85e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—FGFR3—germ cell cancer	1.36e-05	3.84e-05	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—HRAS—germ cell cancer	1.36e-05	3.84e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—KIT—germ cell cancer	1.35e-05	3.83e-05	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—HRAS—germ cell cancer	1.35e-05	3.82e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—KIT—germ cell cancer	1.35e-05	3.82e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.33e-05	3.76e-05	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—TP53—germ cell cancer	1.33e-05	3.76e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—KIT—germ cell cancer	1.31e-05	3.72e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—FGFR3—germ cell cancer	1.3e-05	3.68e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—HRAS—germ cell cancer	1.29e-05	3.66e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TP53—germ cell cancer	1.29e-05	3.66e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—KITLG—germ cell cancer	1.28e-05	3.62e-05	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—HRAS—germ cell cancer	1.27e-05	3.59e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TP53—germ cell cancer	1.27e-05	3.58e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—AVP—germ cell cancer	1.25e-05	3.53e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—KIT—germ cell cancer	1.25e-05	3.52e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—HRAS—germ cell cancer	1.24e-05	3.5e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—HRAS—germ cell cancer	1.23e-05	3.49e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—H2AFZ—germ cell cancer	1.23e-05	3.48e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—HRAS—germ cell cancer	1.22e-05	3.45e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—HRAS—germ cell cancer	1.22e-05	3.44e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—HRAS—germ cell cancer	1.21e-05	3.44e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—HRAS—germ cell cancer	1.21e-05	3.42e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—FGFR3—germ cell cancer	1.2e-05	3.4e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—KIT—germ cell cancer	1.19e-05	3.38e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—HRAS—germ cell cancer	1.19e-05	3.37e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—HRAS—germ cell cancer	1.19e-05	3.35e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—HRAS—germ cell cancer	1.18e-05	3.34e-05	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—HRAS—germ cell cancer	1.17e-05	3.32e-05	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—TP53—germ cell cancer	1.16e-05	3.29e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—FGFR3—germ cell cancer	1.16e-05	3.28e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—HRAS—germ cell cancer	1.14e-05	3.23e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—MYC—germ cell cancer	1.14e-05	3.22e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—KITLG—germ cell cancer	1.13e-05	3.2e-05	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—HRAS—germ cell cancer	1.11e-05	3.15e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AVP—germ cell cancer	1.11e-05	3.13e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—KIT—germ cell cancer	1.1e-05	3.12e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—FGFR3—germ cell cancer	1.08e-05	3.07e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—KIT—germ cell cancer	1.06e-05	3.01e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.05e-05	2.96e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—MYC—germ cell cancer	1.03e-05	2.92e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.03e-05	2.91e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TP53—germ cell cancer	1.03e-05	2.91e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MYC—germ cell cancer	1.01e-05	2.87e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—HRAS—germ cell cancer	1e-05	2.84e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—HRAS—germ cell cancer	1e-05	2.83e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MYC—germ cell cancer	1e-05	2.83e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—KIT—germ cell cancer	9.95e-06	2.82e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—HRAS—germ cell cancer	9.84e-06	2.78e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HRAS—germ cell cancer	9.67e-06	2.74e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—HRAS—germ cell cancer	9.61e-06	2.72e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HRAS—germ cell cancer	9.61e-06	2.72e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MYC—germ cell cancer	9.57e-06	2.71e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—HRAS—germ cell cancer	9.54e-06	2.7e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—FGFR3—germ cell cancer	9.5e-06	2.69e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TP53—germ cell cancer	9.35e-06	2.64e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MYC—germ cell cancer	9.28e-06	2.63e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HRAS—germ cell cancer	9.04e-06	2.56e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HRAS—germ cell cancer	8.94e-06	2.53e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—HRAS—germ cell cancer	8.86e-06	2.51e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HRAS—germ cell cancer	8.78e-06	2.48e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—KIT—germ cell cancer	8.72e-06	2.47e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HRAS—germ cell cancer	8.51e-06	2.41e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—FGFR3—germ cell cancer	8.41e-06	2.38e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CRABP1—germ cell cancer	8.39e-06	2.37e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TP53—germ cell cancer	8.33e-06	2.36e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TP53—germ cell cancer	8.21e-06	2.32e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—HRAS—germ cell cancer	8.11e-06	2.29e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HRAS—germ cell cancer	7.97e-06	2.25e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MYC—germ cell cancer	7.96e-06	2.25e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TP53—germ cell cancer	7.86e-06	2.22e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HRAS—germ cell cancer	7.85e-06	2.22e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MYC—germ cell cancer	7.85e-06	2.22e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—MYC—germ cell cancer	7.82e-06	2.21e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—KIT—germ cell cancer	7.72e-06	2.18e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TP53—germ cell cancer	7.62e-06	2.16e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HRAS—germ cell cancer	7.51e-06	2.13e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MYC—germ cell cancer	7.45e-06	2.11e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HRAS—germ cell cancer	7.29e-06	2.06e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HRAS—germ cell cancer	7.28e-06	2.06e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MYC—germ cell cancer	7.23e-06	2.05e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—HRAS—germ cell cancer	7.11e-06	2.01e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HRAS—germ cell cancer	7.08e-06	2e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—MYC—germ cell cancer	6.85e-06	1.94e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HRAS—germ cell cancer	6.65e-06	1.88e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TP53—germ cell cancer	6.54e-06	1.85e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TP53—germ cell cancer	6.45e-06	1.82e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HRAS—germ cell cancer	6.25e-06	1.77e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HRAS—germ cell cancer	6.17e-06	1.74e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—HRAS—germ cell cancer	6.14e-06	1.74e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TP53—germ cell cancer	6.11e-06	1.73e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—MYC—germ cell cancer	6.07e-06	1.72e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TP53—germ cell cancer	5.94e-06	1.68e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MYC—germ cell cancer	5.85e-06	1.66e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HRAS—germ cell cancer	5.85e-06	1.65e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—HRAS—germ cell cancer	5.83e-06	1.65e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HRAS—germ cell cancer	5.68e-06	1.61e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MYC—germ cell cancer	5.48e-06	1.55e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—HRAS—germ cell cancer	5.38e-06	1.52e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HRAS—germ cell cancer	5.16e-06	1.46e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TP53—germ cell cancer	4.81e-06	1.36e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MYC—germ cell cancer	4.8e-06	1.36e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—HRAS—germ cell cancer	4.76e-06	1.35e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HRAS—germ cell cancer	4.6e-06	1.3e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TP53—germ cell cancer	4.5e-06	1.27e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HRAS—germ cell cancer	4.3e-06	1.22e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MYC—germ cell cancer	4.25e-06	1.2e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TP53—germ cell cancer	3.94e-06	1.12e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HRAS—germ cell cancer	3.77e-06	1.07e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TP53—germ cell cancer	3.49e-06	9.87e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HRAS—germ cell cancer	3.34e-06	9.44e-06	CbGpPWpGaD
